2024-9-23
1. Summary of the week
From September 14 to 20, 14 licensing and collaboration deals were signed globally. In the China Biotech Industry, Altamira Therapeutics secured an in-licensing agreement with Nuance Pharma for Bentrio®, expanding its reach across Southeast and East Asia. Additionally, Betta Pharmaceuticals signed a regional distribution agreement with Healthgen Biotechnology for plant-derived OsrHSA, and Huisheng Bio partnered with Huadong Medicine for the exclusive commercialization of Janagliflozin.
Globally, 11 licensing and cooperation agreements were finalized that week, with the largest being between Capricor Therapeutics and Nippon Shinyaku for the Phase III asset Deramiocel, valued at $735 million, which includes a $20 million upfront payment.
9月14日到20日，全球医药市场共完成了14项授权和合作协议，中国医药市场占了3项，2项国内交易和1项引进交易。Altamira Therapeutics与优锐医药达成协议，将Bentrio独家授权范围扩展到东南亚和东亚的多个国家和地区。禾元生物授权贝达药业在约定区域内独家经销植物源重组人血清白蛋白注射液。惠升生物与华东医药就一类新药惠优静（加格列净片）在中国大陆的商业化权益达成独家战略合作。
在全球范围内，共签署了11项协议。其中最大的一项交易是Nippon Shinyaku引进Capricor Therapeutics一临床三期资产Deramiocel，首付款2000万美元，总价值7.35亿美元。
2. Licensing Deals
2a. China section
2b. Global section
3. M&A Deals
4. Top Deals of the year 2024
5. 2019-2023 China Innovative Drug Licensing Transactions
About YAFO Capital
Founded in 2013, YAFO Capital is a Shanghai-based boutique investment and advisory firm, with professional team in our China, U.S., EU and SEA offices. Partnering with Pharmaceutical companies, YAFO Fund mainly invests in global assets. YAFO Life Sciences is a leading advisory boutique focused on asset transactions. YAFO has built a strong proven track record and closed dozens of in-licensing and out-licensing transactions with global pharma and biotech companies. Over the past five years, YAFO has been ranked as the No. 1 advisor for China cross border licensing transactions. For more information, please visit http://www.yafocapital.com
ACCESS CHINA
Event Name:
2024-09 药通中国秋季路演，线上&云南
2024-09 ACCESS CHINA Autumn Roadshow, Virtual & Yunnan
2025-01 药通中国论坛@JPM，线上&旧金山
2025-01 ACCESS CHINA @ JPM Week, Virtual & San Francisco
BioToChina.org 